| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3843448 | Actas Urológicas Españolas | 2014 | 8 Pages |
Abstract
Despite the potential limitations of the study, the vulnerable elderly non institutionalized patients with OAB treated with fesoterodine, compared to solifenacin or tolterodine were associated with lower resource utilization and healthcare costs.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
A. Sicras-Mainar, J. Rejas-Gutiérrez, R. Navarro-Artieda, A. Aguado-Jodar, A. RuÃz-Torrejón,